Galapagos NV: business update: http://t.co/6w1jppWE
posted 6 days ago
FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.
Patrik De Haes has been appointed as the new chairman of the Board of Directors of FlandersBio. He succeeds Johan Cardoen who stands down after five years in the post. Patrik De Haes, who is the CEO of ThromboGenics, has been a director of FlandersBio for the last two years. read more
Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international stem cell storage company and the largest family stem cell bank in Europe, is happy to welcome Ms. Karin Dorrepaal, PhD, MBA as its new Non-Executive Director. read more
Amakem NV, a kinase platform company focusing on ophthalmology, today announces the appointment of Dr. Steve Pakola as Chief Medical Officer and Dr. George Lasezkay to its Board as an Independent Director. Both have exceptional track records in the biotechnology industry and bring a wealth of ophthalmology experience to Amakem. read more
Trinean NV today announced the appointment of Philippe Stas as it’s new CEO, succeeding Dr. Marc Zabeau, who remains a member of the board of directors. Simultaneously, Trinean announced that the company has secured 2.7 million euro of growth financing provided by its existing investors. read more
In line with its continuous efforts to improve internal stem cell procedures, Cryo-Save proudly announces the appointment of the highly knowledgeable stem cell expert Dr. Marcin Jurga. read more
Earlier this year Rudy Dekeyser announced his departure from VIB, to accept a new challenge in the venture capital world. Since the start of VIB in July 1995, VIB has been led by the tandem Jo Bury and Rudy Dekeyser. From June 1st onwards Johan Cardoen will succeed Rudy Dekeyser as managing director and director tech transfer of VIB. read more
genae, a leading Contract Research Organization (CRO) and services provider for the medical device industries, today announced that Catalina Trana, MD, has been appointed Chief Medical Officer. In this role, Dr. Trana will be responsible for all clinical, safety and risk management related to genae's research services. read more
TiGenix NV (NYSE Euronext: TIG), a leader in the field of cell therapy, today announced the appointment of Dr. Guido Schopen as vice president commercial operations. Dr. Schopen brings to TiGenix more than 20 years of bio-pharmaceutical industry experience. In addition to his global commercial responsibilities, Dr. Schopen, who is a German national, will also assume the role of country manager Germany. read more
